Archer Aviation: Buy, Sell, or Hold?

Archer Aviation’s stock has fallen more than 62% from above $14 to about $5.50 amid investor concern over certification and cash burn. The company still lacks FAA certification for its Midnight eVTOL and is in the final stage of the FAA process, though it plans limited U.S. operations in late 2026 under the eVTOL Integration Pilot Program and expects defense revenue via Anduril’s autonomous VTOL platforms. Despite about $1.6B in cash/investments at end-June and low debt, widening losses, minimal revenue, and a likely need for a future cash injection imply further dilution risk.

Analysis

The market is treating ACHR like an execution story, but the real issue is capital intensity versus timetable uncertainty. When a pre-revenue platform trades on milestone optionality, every quarter of delay forces the equity to finance more of the R&D curve, which is why dilution—not technology—is the main driver of multiple compression here. That makes near-term downside asymmetric: even if FAA progress is real, the stock can still leak lower if the company needs a larger-than-expected raise before first meaningful commercial cash flow.

The second-order winner is less the company itself than adjacent suppliers and financing ecosystems that can monetize the buildout without taking certification risk: avionics, battery, components, and defense-adjacent autonomy players. If the defense pathway becomes the first durable revenue stream, the commercial air-taxi thesis effectively gets repriced as a long-dated call option rather than a standalone operating business. That would help the defense JV ecosystem, but it also means public-market investors may be paying for an addressable urban-mobility market that is still years from being economically testable.

Consensus may be underweighting how unforgiving the runway math is. A balance sheet that looks adequate today can still be consumed quickly by manufacturing prep, certification work, and field ops before any unit economics are proven. The key falsifiers over the next 1-3 months are: a materially smaller equity raise than expected, a hard FAA milestone, or a signed defense contract with disclosed economics; absent that, the stock can remain a funding-overhang trade rather than a fundamentals trade.

Key Decisions for Investors

• Stay underweight/short ACHR into strength; thesis is that the equity remains a financing instrument until a credible revenue bridge appears. Use a 1-3 month horizon and cover only if management pre-announces non-dilutive funding or a major certification gate is cleared.
• Pair trade: short ACHR vs. long a cash-generative aerospace/defense proxy (e.g., BA or LHX) to isolate execution and financing risk from sector beta. The trade works if ACHR underperforms on any capital raise or delay headlines over the next 1-2 quarters.
• If trading options, prefer ACHR put spreads rather than outright puts: the name can rip on headline certification progress, but downside should reassert if dilution/operating burn dominates. Target expiry around the next funding or FAA milestone window.
• Set an alert for any equity issuance, convert, or ATM expansion. A larger-than-expected raise would be the cleanest thesis confirmation that the market is being asked to fund a longer runway than it currently prices.
• Watch JOBY as the closest public comparator: if JOBY begins to re-rate higher on better certification visibility while ACHR lags, a relative-short ACHR/JOBY pair can express the view that capital structure quality matters more than narrative intensity.